WallStreetZenWallStreetZen

NASDAQ: HITI
High Tide Inc Stock Forecast, Predictions & Price Target

Analyst price target for HITI

Based on 1 analyst offering 12 month price targets for High Tide Inc.
Min Forecast
$4.50+99.12%
Avg Forecast
$4.50+99.12%
Max Forecast
$4.50+99.12%

Should I buy or sell HITI stock?

Based on 1 analyst offering ratings for High Tide Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HITI stock forecasts and price targets.

HITI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-25

1 of 1

Forecast return on equity

Is HITI forecast to generate an efficient return?

Forecast return on assets

Is HITI forecast to generate an efficient return on assets?

HITI revenue forecast

What is HITI's revenue in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
$387.5M-22.14%
Avg 2 year Forecast
$451.9M-9.2%
Avg 3 year Forecast
$592.7M+19.11%
HITI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

HITI revenue growth forecast

How is HITI forecast to perform vs Pharmaceutical Retailers companies and vs the US market?
Company
4.26%
Industry
3%
Market
10.06%
HITI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HITI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HITI vs Pharmaceutical Retailer Stocks

TickerPricePrice TargetUp/downsideConsensus
HITI$2.26$4.50+99.12%Strong Buy
PETS$4.11$6.50+58.15%Strong Sell
YI$1.02N/AN/A
BIMI$1.28N/AN/A
MEDS$6.43N/AN/A

High Tide Stock Forecast FAQ

Is High Tide Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: HITI) stock is to Strong Buy HITI stock.

Out of 1 analyst, 1 (100%) are recommending HITI as a Strong Buy, 0 (0%) are recommending HITI as a Buy, 0 (0%) are recommending HITI as a Hold, 0 (0%) are recommending HITI as a Sell, and 0 (0%) are recommending HITI as a Strong Sell.

If you're new to stock investing, here's how to buy High Tide stock.

What is HITI's revenue growth forecast for 2024-2026?

(NASDAQ: HITI) High Tide's forecast annual revenue growth rate of 4.26% is forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 3%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.06%.

High Tide's revenue in 2024 is $497,661,000.On average, 3 Wall Street analysts forecast HITI's revenue for 2024 to be $30,438,589,669, with the lowest HITI revenue forecast at $30,363,960,252, and the highest HITI revenue forecast at $30,502,221,067. On average, 3 Wall Street analysts forecast HITI's revenue for 2025 to be $35,496,578,764, with the lowest HITI revenue forecast at $34,786,735,172, and the highest HITI revenue forecast at $36,495,356,034.

In 2026, HITI is forecast to generate $46,564,042,740 in revenue, with the lowest revenue forecast at $46,564,042,740 and the highest revenue forecast at $46,564,042,740.

What is HITI's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: HITI) forecast ROA is N/A, which is lower than the forecast US Pharmaceutical Retailers industry average of N/A.

What is HITI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year HITI price target, the average HITI price target is $4.50, with the highest HITI stock price forecast at $4.50 and the lowest HITI stock price forecast at $4.50.

The Wall Street analyst predicted that High Tide's share price could reach $4.50 by Mar 25, 2025. The average High Tide stock price prediction forecasts a potential upside of 99.12% from the current HITI share price of $2.26.

What is HITI's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: HITI) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.